BMC Cardiovascular Disorders (Jun 2011)

Racial variation in lipoprotein-associated phospholipase A<sub>2 </sub>in older adults

  • Go Alan S,
  • Fair Joan M,
  • Varady Ann,
  • Fortmann Stephen P,
  • Lee Keane K,
  • Quertermous Thomas,
  • Hlatky Mark A,
  • Iribarren Carlos

DOI
https://doi.org/10.1186/1471-2261-11-38
Journal volume & issue
Vol. 11, no. 1
p. 38

Abstract

Read online

Abstract Background Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a predictor of cardiovascular events that has been shown to vary with race. The objective of this study was to examine factors associated with this racial variation. Methods We measured Lp-PLA2 mass and activity in 714 healthy older adults with no clinical coronary heart disease and not taking dyslipidemia medication. We evaluated the association between race and Lp-PLA2 mass and activity levels after adjustment for various covariates using multivariable linear regression. These covariates included age, sex, diabetes, hypertension, body mass index, lipid measurements, C-reactive protein, smoking status, physical activity, diet, income, and education level. We further examined genetic covariates that included three single nucleotide polymorphisms shown to be associated with Lp-PLA2 activity levels. Results The mean age was 66 years. Whites had the highest Lp-PLA2 mass and activity levels, followed by Hispanics and Asians, and then African-Americans; in age and sex adjusted analyses, these differences were significant for each non-White race as compared to Whites (p 2 mass and 24.7 nmol/ml-min lower activity, compared with Whites, independent of age and sex (p 2 mass and activity levels (p 2 mass and 17.3 nmol/ml-min lower activity compared with Whites (p Conclusion Biological, lifestyle, demographic, and select genetic factors do not appear to explain variations in Lp-PLA2 mass and activity levels between Whites and non-Whites, suggesting that Lp-PLA2 mass and activity levels may need to be interpreted differently for various races.